Skip to main content
. 2022 Apr;10(4):253–263. doi: 10.1016/S2213-8587(22)00033-X

Table 2.

Association of BMI category with incident obesity-related disease and multimorbidity

First disease
Second disease
Third disease
Fourth disease
Incident cases HR (95% CI)* PAF (95% CI) Incident cases HR (95% CI)* PAF (95% CI) Incident cases HR (95% CI)* PAF (95% CI) Incident cases HR (95% CI)* PAF (95% CI)
Finnish cohorts
Underweight (n=1476) 161 0·80 (0·69- to 0·94) −0·2% (−0·4 to −0·1) 29 0·95 (0·66 to 1·37) 0% (−0·3 to 0·3) 8 .. .. 1 .. ..
Healthy weight (n=55 857) 9373 1 (ref) 0% (ref) 1676 1 (ref) 0% (ref) 309 1 (ref) 0% (ref) 62 1 (ref) 0% (ref)
Overweight (n=24 495) 6813 1·53 (1·49 to 1·58) 9·6% (8·9 to 10·2) 1764 1·89 (1·77 to 2·03) 12·1% (10·9 to 13·3) 431 2·30 (1·98 to 2·66) 13·4% (11·3 to 15·4) 104 2·67 (1·94 to 3·68) 13·3% (9·6 to 16·3)
Obesity (n=14 867) 5672 2·83 (2·74 to 2·93) 19·9% (19·3 to 20·5) 2058 5·17 (4·84 to 5·53) 34·4% (33·2 to 35·5) 645 8·18 (7·12 to 9·39) 45·2% (43·1 to 47·0) 195 12·39 (9·26 to 16·58) 55·2% (50·9 to 57·5)
Class 1 obesity (n=12 496) 4519 2·63 (2·53 to 2·72) 14·8% (14·3 to 15·3) 1565 4·61 (4·30 to 4·95) 24·9% (24·1 to 25·7) 454 6·77 (5·85 to 7·85) 30·4% (29·0 to 31·5) 127 9·56 (7·02 to 13·02) 34·9% (32·2 to 35·9)
Class 2 obesity (n=1839) 875 3·80 (3·54 to 4·07) 3·8% (3·5 to 4·0) 358 7·39 (6·59 to 8·29) 6·5% (6·0 to 7·0) 136 13·63 (11·12 to 16·71) 9·8% (8·9 to 10·6) 53 25·55 (17·63 to 37·04) 14·7% (13·1 to 15·9)
Class 3 obesity (n=532) 278 4·99 (4·43 to 5·62) 1·5% (1·4 to 1·7) 135 12·43 (10·42 to 14·82) 3·4% (2·9 to 3·8) 55 25·22 (18·91 to 33·64) 5·4% (4·6 to 6·4) 15 33·56 (19·04 to 59·13) 5·7% (4·1 to 7·4)
UK Biobank cohort
Underweight (n=2387) 423 1·09 (0·99 to 1·20) <0·1% (0·0 to 0·1) 74 1·09 (0·87 to 1·38) 0% (−0·1 to 0·1) 20 1·46 (0·94 to 2·28) 0·2% (0·0 to 0·4) 5 .. ..
Healthy weight (n=150 423) 25787 1 (ref) 0% (ref) 4620 1 (ref) 0% (ref) 949 1 (ref) 0% (ref) 203 1 (ref) 0% (ref)
Overweight (n=188 761) 43 734 1·28 (1·26 to 1·30) 8·9% (8·4 to 9·4) 9149 1·36 (1·31 to 1·41) 10·3% (9·2 to 11·4) 2032 1·40 (1·30 to 1·51) 10·3% (8·1 to 12·4) 482 1·49 (1·27 to 1·76) 11·1% (6·9 to 14·9)
Obesity (n=100 510) 31 931 1·88 (1·85 to 1·91) 15·2% (14·8 to 15·5) 8638 2·48 (2·39 to 2·57) 22·6% (21·8 to 23·3) 2390 3·12 (2·89 to 3·36) 29·1% (27·6 to 30·5) 691 3·99 (3·41 to 4·68) 35·9% (33·0 to 38·4)
Class 1 obesity (n=73 494) 21 912 1·71 (1·68 to 1·74) 8·9% (8·6 to 9·2) 5569 2·12 (2·04 to 2·20) 12·4% (11·9 to 12·9) 1433 2·47 (2·27 to 2·68) 14·6% (13·6 to 15·6) 388 2·95 (2·49 to 3·51) 16·9% (14·9 to 18·5)
Class 2 obesity (n=19 767) 7048 2·24 (2·18 to 2·30) 4·2% (4·0 to 4·3) 2051 3·15 (2·99 to 3·32) 6·4% (6·1 to 6·7) 623 4·37 (3·95 to 4·84) 9·0% (8·5 to 9·6) 198 6·18 (5·07 to 7·53) 12·0% (11·0 to 13·0)
Class 3 obesity (n=7249) 2971 2·90 (2·79 to 3·01) 2·4% (2·3 to 2·5) 1018 4·95 (4·62 to 5·30) 4·3% (4·1 to 4·5) 334 7·53 (6·64 to 8·54) 6·4% (5·9 to 6·9) 105 10·64 (8·39 to 13·50) 8·2% (7·3 to 9·1)

Data are n unless otherwise stated. HR=hazard ratio. PAF=population attributable fraction.

*

Adjusted for age, sex, ethnicity (UK Biobank), cohort (Finnish cohorts), education, and neighbourhood deprivation.